1972
DOI: 10.1016/0002-9343(72)90021-6
|View full text |Cite
|
Sign up to set email alerts
|

Procainamide-induced lupus erythematosus

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
9
0
1

Year Published

1975
1975
1985
1985

Publication Types

Select...
10

Relationship

1
9

Authors

Journals

citations
Cited by 198 publications
(11 citation statements)
references
References 29 publications
1
9
0
1
Order By: Relevance
“…Individuals that develop this reaction have antinuclear antibodies as well as antibodies to DNA and nucleoproteins (6)(7)(8)(9)(10)(11)(12)(13). In vitro studies have also demonstrated interaction of systemic lupus erythematosus-inducing drugs with DNA (11,14,15).…”
mentioning
confidence: 99%
“…Individuals that develop this reaction have antinuclear antibodies as well as antibodies to DNA and nucleoproteins (6)(7)(8)(9)(10)(11)(12)(13). In vitro studies have also demonstrated interaction of systemic lupus erythematosus-inducing drugs with DNA (11,14,15).…”
mentioning
confidence: 99%
“…Recent etiologic hypotheses for SLE suggest that, given a predisposition, an environmental factor, such as a drug or a viral infection, may elicit manifest disease (20,21). T h e study of monozygotic twins discordant for SLE thus provides a unique opportunity to study environmental influences that might explain the development of disease in only one of two individuals of identical genotype.…”
Section: Discussionmentioning
confidence: 99%
“…One of the well-documented hazards of procainamide therapy is the development of systemic lupus erythematosis (Ladd, 1962;Blomgren, Condemi & Vaughan, 1972;Kosowsky, Taylor, Lown & Ritchie, 1973). This may present with polyarthralgia, myalgia, pleurisy or fever.…”
Section: Methodsmentioning
confidence: 99%